title: Beta-lapachone micellar nanotherapeutics for non-small cell lung cancer therapy.
abstract: Lung cancer is the leading cause of cancer-related deaths with current chemotherapies lacking adequate specificity and efficacy. Beta-lapachone (beta-lap) is a novel anticancer drug that is bioactivated by NAD(P)H:quinone oxidoreductase 1, an enzyme found specifically overexpressed in non-small cell lung cancer (NSCLC). Herein, we report a nanotherapeutic strategy that targets NSCLC tumors in two ways: (a) pharmacodynamically through the use of a bioactivatable agent, beta-lap, and (b) pharmacokinetically by using a biocompatible nanocarrier, polymeric micelles, to achieve drug stability, bioavailability, and targeted delivery. Beta-lap micelles produced by a film sonication technique were small ( approximately 30 nm), displayed core-shell architecture, and possessed favorable release kinetics. Pharmacokinetic analyses in mice bearing subcutaneous A549 lung tumors showed prolonged blood circulation (t(1/2), approximately 28 h) and increased accumulation in tumors. Antitumor efficacy analyses in mice bearing subcutaneous A549 lung tumors and orthotopic Lewis lung carcinoma models showed significant tumor growth delay and increased survival. In summary, we have established a clinically viable beta-lap nanomedicine platform with enhanced safety, pharmacokinetics, and antitumor efficacy for the specific treatment of NSCLC tumors.
authors.affiliation: Departments of Pharmacology, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center at Dallas, Texas 75390-8807, USA.
authors.forename: Elvin
authors.initials: E
authors.lastname: Blanco
authors.forename: Erik A
authors.initials: EA
authors.lastname: Bey
authors.forename: Chalermchai
authors.initials: C
authors.lastname: Khemtong
authors.forename: Su-Geun
authors.initials: SG
authors.lastname: Yang
authors.forename: Jagadeesh
authors.initials: J
authors.lastname: Setti-Guthi
authors.forename: Huabing
authors.initials: H
authors.lastname: Chen
authors.forename: Chase W
authors.initials: CW
authors.lastname: Kessinger
authors.forename: Kevin A
authors.initials: KA
authors.lastname: Carnevale
authors.forename: William G
authors.initials: WG
authors.lastname: Bornmann
authors.forename: David A
authors.initials: DA
authors.lastname: Boothman
authors.forename: Jinming
authors.initials: J
authors.lastname: Gao
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000493:pharmacokinetics / Q000494:pharmacology; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy / Q000473:pathology; D045744:Cell Line, Tumor; D004337:Drug Carriers / Q000737:chemistry*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000473:pathology; D051379:Mice; D008819:Mice, Nude; D008823:Micelles; D016660:NAD(P)H Dehydrogenase (Quinone) / Q000037:antagonists & inhibitors* / Q000378:metabolism; D050997:Nanomedicine; D009285:Naphthoquinones / Q000493:pharmacokinetics / Q000494:pharmacology*; D015996:Survival Rate; D014018:Tissue Distribution; D023041:Xenograft Model Antitumor Assays
chemical_list: D000970:Antineoplastic Agents; D004337:Drug Carriers; D008823:Micelles; D009285:Naphthoquinones; C014638:beta-lapachone; D016660:NAD(P)H Dehydrogenase (Quinone); C447479:NQO1 protein, human
references.citation: J Control Release. 2000 Mar 1;65(1-2):271-84
references.pmid: 10699287
references.citation: Clin Cancer Res. 2009 Jan 1;15(1):131-9
references.pmid: 19118040
references.citation: Am J Pathol. 2000 Apr;156(4):1363-80
references.pmid: 10751361
references.citation: Nat Biotechnol. 2005 Dec;23(12):1517-26
references.pmid: 16333296
references.citation: Int J Pharm. 2002 Mar 20;235(1-2):179-92
references.pmid: 11879753
references.citation: J Biol Chem. 1998 Mar 27;273(13):7382-9
references.pmid: 9516435
references.citation: Nat Rev Neurosci. 2007 Aug;8(8):610-22
references.pmid: 17643088
references.citation: Adv Enzyme Regul. 2001;41:189-207
references.pmid: 11384745
references.citation: Oncol Rep. 2005 Jan;13(1):157-60
references.pmid: 15583818
references.citation: J Control Release. 2001 Jun 15;73(2-3):137-72
references.pmid: 11516494
references.citation: J Mol Histol. 2006 Sep;37(5-7):203-18
references.pmid: 16868862
references.citation: Pharm Res. 2003 Oct;20(10):1626-33
references.pmid: 14620518
references.citation: Nat Nanotechnol. 2007 Dec;2(12):751-60
references.pmid: 18654426
references.citation: Exp Biol Med (Maywood). 2009 Feb;234(2):123-31
references.pmid: 19064945
references.citation: Infect Immun. 2000 Nov;68(11):6419-22
references.pmid: 11035754
references.citation: Proc Natl Acad Sci U S A. 2007 Jul 10;104(28):11832-7
references.pmid: 17609380
references.citation: Cancer Res. 2009 Feb 15;69(4):1651-8
references.pmid: 19190328
references.citation: Cancer Invest. 2001;19(4):424-36
references.pmid: 11405181
references.citation: Science. 2003 Apr 25;300(5619):615-8
references.pmid: 12714738
references.citation: CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49
references.pmid: 19474385
references.citation: Bioorg Med Chem. 2008 May 15;16(10):5635-43
references.pmid: 18424157
references.citation: J Appl Physiol (1985). 2006 Feb;100(2):615-22
references.pmid: 16223982
references.citation: Biochem Pharmacol. 1991 Aug 8;42(5):1021-7
references.pmid: 1651729
references.citation: Eur J Pharm Biopharm. 2007 Mar;65(3):309-19
references.pmid: 17257817
references.citation: Cancer Res. 1995 Sep 1;55(17):3706-11
references.pmid: 7641180
references.citation: J Control Release. 2001 Nov 9;77(1-2):27-38
references.pmid: 11689257
references.citation: J Control Release. 2007 Oct 8;122(3):365-74
references.pmid: 17574288
references.citation: J Control Release. 2004 Aug 27;98(3):415-26
references.pmid: 15312997
references.citation: Angew Chem Int Ed Engl. 2004 Jan 3;43(3):278-82
references.pmid: 14705079
references.citation: Nat Rev Cancer. 2005 Mar;5(3):161-71
references.pmid: 15738981
references.citation: Cancer Metastasis Rev. 1993 Jun;12(2):103-17
references.pmid: 8375015
references.citation: Br J Cancer. 1999 Mar;79(7-8):1121-6
references.pmid: 10098745
references.citation: Cancer Res. 2007 Jul 15;67(14):6936-45
references.pmid: 17638905
references.citation: Pharm Res. 2007 Jun;24(6):1029-46
references.pmid: 17385025
references.citation: J Biol Chem. 2000 Feb 25;275(8):5416-24
references.pmid: 10681517